Could a 3-Step immune therapy save Insulin-Making cells in newly diagnosed type 1 diabetes?
Disease control
Not yet recruiting
This early-phase trial tests a three-step immune treatment for people recently diagnosed with Type 1 diabetes (within 6 months). The goal is to preserve the body's remaining insulin production by calming the immune attack and teaching the immune system to tolerate insulin. Sixty …
Phase: PHASE1 • Sponsor: Abdullah Kars • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC